Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
IGEA Pharma N.V. logo — Harnessing the wealth of nature and innovative technologies...

IGEA Pharma N.V.

Harnessing the wealth of nature and innovative technologies to improve human health

Founded 2018 The Netherlands The Netherlands 2-10 employees Post-IPO Debt Total: $2.00M Biotechnology, Health Care

General Information

Company Name IGEA Pharma N.V.
Founded Year 2018
Location The Netherlands The Netherlands
Employees 2-10
Industries Biotechnology, Health Care
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with IGEA Pharma N.V.. To contact IGEA Pharma N.V., visit igeapharma.nl.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does IGEA Pharma N.V. compare?

A PDF of IGEA Pharma N.V. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting IGEA Pharma N.V. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About IGEA Pharma N.V.

IGEA Pharma N.V. is a biotechnology and healthcare startup based in Hoofddorp, The Netherlands. Founded in 2018, the company's slogan "Harnessing the wealth of nature and innovative technologies to improve human health" reflects its commitment to leveraging natural resources and cutting-edge technology to enhance human well-being.

The company functions as a holding company, with its shares listed on SIX in Zurich, Switzerland. IGEA Pharma N.V. specializes in transforming natural resources into functional food, food supplements, and high-tech products for the cosmetic and pharma industries, while also focusing on health-tech and med-tech products and devices.

As of 15 April 2021, the company received a €2.00M Post-IPO Debt investment from Negma Group. It operates development, production, and commercialization entities in Italy, Switzerland, and the United States. The company's current focal points include health prevention and nutraceutical solutions with a focus on hemp, policosanol, and ikuvia extracts based on CO2 supercritical extraction, as well as preventative health-tech products for Alzheimer’s and diabetes. Additionally, they develop med-tech products for air and inanimate environmental surface sanitization with aerosol technology-based devices.

Business keywords: pharmaceutical, health-tech, med-tech, innovative technologies, functional food, nutraceutical, health prevention, supplements, cosmetic industry, Alzheimer's prevention, diabetes prevention, CO2 supercritical extraction, natural resources, SIX listed

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €2.00M 1
Negma Group
Negma Group
15 Apr 2021

IGEA Pharma N.V. Alternatives & Competitors

IGEA Pharma N.V. vs
Canax
Canax Italy

Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali i...

Debt Financing
4 employees
Biotechnology, Health Care
IGEA Pharma N.V. vs
FERMENTALG
FERMENTALG France

Natural Algae Solutions

Secondary Market
87 employees
Biotechnology, Energy

FAQ About IGEA Pharma N.V.

Harnessing the wealth of nature and innovative technologies to improve human health
IGEA Pharma N.V. was founded in 2018.
IGEA Pharma N.V. is headquartered in The Netherlands.
IGEA Pharma N.V. operates in Biotechnology and Health Care. Its work centres on pharmaceutical, health-tech, med-tech and innovative technologies.
IGEA Pharma N.V. has approximately 2-10 employees.
IGEA Pharma N.V. has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to IGEA Pharma N.V. include Canax, FERMENTALG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IGEA Pharma N.V. and Canax are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IGEA Pharma N.V., https://bouncewatch.com/company/igea-pharma-nv, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout